Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 351,959 | 383,523 | 390,122 | 360,203 | 354,072 |
| Cost of Goods | 169,794 | 170,187 | 171,604 | 158,106 | 165,409 |
| Gross Profit | 182,165 | 213,336 | 218,518 | 202,097 | 188,663 |
| Operating Expenses | 148,158 | 141,334 | 135,903 | 132,157 | 127,746 |
| Operating Income | 34,801 | 72,189 | 83,219 | 70,046 | 61,326 |
| Interest Expense | 5,396 | 4,294 | 2,965 | 2,774 | 1,909 |
| Other Income | 457 | 313 | 488 | 471 | 541 |
| Pre-tax Income | 29,862 | 68,208 | 80,742 | 67,743 | 59,958 |
| Income Tax | 3,911 | 16,045 | 23,498 | 21,150 | 16,722 |
| Net Income Continuous | 25,951 | 52,163 | 57,244 | 46,593 | 43,236 |
| Minority Interests | -10 | 21 | 26 | 8 | -21 |
| Net Income | $25,961 | $52,142 | $57,218 | $46,585 | $43,257 |
| EPS Basic Total Ops | 0.29 | 0.52 | 0.56 | 0.45 | 0.42 |
| EPS Basic Continuous Ops | 0.28 | 0.52 | 0.56 | 0.45 | 0.42 |
| EPS Diluted Total Ops | 0.28 | 0.52 | 0.55 | 0.45 | 0.41 |
| EPS Diluted Continuous Ops | 0.28 | 0.52 | 0.55 | 0.45 | 0.41 |
| EBITDA(a) | $50,079 | $87,710 | $97,914 | $83,440 | $74,792 |